Mike has developed expertise across a range of therapeutic areas in his decade-long career in the life science commercialization space. This has involved leading a range of engagements with a diverse set of life science companies spanning products, franchises, and therapeutic areas. Mike has developed a particular focus in oncology and rare disease. He has extensive experience in the vaccine space in both commercial vaccines and stockpiled and pandemic vaccines. Mike has also developed a particular expertise in product planning and portfolio strategy as well as launch readiness, commercialization strategy, and diligence support.
Prior to joining ClearView, Mike completed a Ph.D. in Biochemistry from Wake Forest University. After receiving his doctorate, Mike completed a postdoctoral fellowship with the NIH in DNA mismatch repair and has extensive commercialization experience from his time leading sales and marketing in the U.S. and Canada with a life science instrumentation manufacturer.
Bill Shew
David Gilman
David McClain
Debbi Amanti Belanger
Debbie Zhuang
Ketan Kapadia
Kevin Richard
Kim Goh
Klaus Bredl
Mike Rizzo
Philip Kenner
Richard Mynahan
Rishi Dalsania
Ryan Tubman
Sam Ulin
Seth Berman
Stephen Chang
Steven Chao
Stuart MacGregor
Jim Caruso
Sidnee Pinho
Kristine Hyde
Charles Mathews
Dave Konciak
Dean Griffiths
Jonathan Betts
Jonathan Hodgson
Mike Roy
Slater Hurst
Alec Marchuk
Alexander Lehrman
Allana Sanborn
Andrew Kang
Austin Hubbert
Beko Binder
Cem Salfati
Jessica Berard
Joanna Lee
Jonny Juliano
Kai-Ming Pu
Kelsey Yardumian
Maneesh Gujrati
Matthew Murphy
Matthew Pfister
Mike Murray
Olivia Piccione
Owen Im
Patrick Kuettner
Peter Goldman
Sarah Stapleton
Soyeon Park
Vini De Nadai
Steve Rubman
Lainey Miller